MI
PRDS

MMCAP International’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

MMCAP International’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,530
Closed -$164K – 483
2021
Q3 		$164K Hold
16,530
– – 0.01% 332
2021
Q2 		$165K Sell
16,530
-7,416
-31% -$74.4K 0.01% 311
2021
Q1 		$239K Buy
+23,946
New +$248K 0.02% 249

Other funds holding PRDS

FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
JCM
JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return

MMCAP International's PRDS Position: Q4 2021 in Review

MMCAP International sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q4 2021, closing a stake of 16,530 shares — an estimated $164K sold.

MMCAP International first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $239K in Q1 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.

  • MMCAP International reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • MMCAP International sold 16,530 Pardes Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $164K.
  • MMCAP International first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • MMCAP International's Pardes Biosciences, Inc. Common Stock position peaked at $239K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q4 2021.

Based on MMCAP International's 13F filing for Q4 2021, filed 9 Feb 2022.